Glyxambi 25 mg/5 mg TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: empagliflozin + linagliptin
Brand name
(ARTG)
: GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate (see Sections 4.2 Dose and method of administration and 5.1 Pharmacodynamic properties Clinical trials).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Pale pink, arc triangular, flat-faced, bevel-edged, film-coated tablets. One side debossed with the BI company symbol, the other debossed with "25/5".
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 (sample pack) pack
- 30 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient empagliflozin + linagliptin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
